Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency
- 31 December 1988
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 116 (6), 1772-1777
- https://doi.org/10.1016/0002-8703(88)90228-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Doxazosin in patients with hypertensionEuropean Journal of Clinical Pharmacology, 1988
- Coronary risk prediction in adults (The Framingham Heart Study)The American Journal of Cardiology, 1987
- Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.British Journal of Clinical Pharmacology, 1986
- Multicentre 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- The metabolism and kinetics of doxazosin in man, mouse, rat and dog.British Journal of Clinical Pharmacology, 1986
- Doxazosin, an alpha 1‐adrenoceptor antagonist: pharmacokinetics and concentration‐effect relationships in man.British Journal of Clinical Pharmacology, 1983
- Summary estimates of cholesterol used to predict coronary heart disease.Circulation, 1983
- A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.British Journal of Clinical Pharmacology, 1982
- Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in ManJournal of Cardiovascular Pharmacology, 1982
- Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant PatientsNew England Journal of Medicine, 1977